Evaluation of Treatments for Sore Throat Associated With Acute Pharyngitis and/or Viral Tonsillitis
Condition(s) studied
Investigational drug(s) / intervention(s)
HMG: Patients included in the "HMG" arm will receive the medical device of the same name.
PHN: Patients included in the "PHN" arm will receive the medical device of the same name.
PHR: Patients included in the "PHR" arm will receive the medical device of the same name.
TUR: Patients included in the "TUR" arm will receive the medical device of the same name.
Study summary
The objective of this study is to conduct post-marketing clinical follow-up of four products: HMG, PHN, PHR, and TUR. This follow-up will consist of collecting clinical data in real-life conditions to confirm the tolerance, safety, and efficacy of medical devices used in the treatment of sore throats related to acute pharyngitis and/or viral-origin tonsillitis, while also assessing the benefit/risk ratio of the products.
Eligibility
Primary outcome measure(s)
- Tolerance — From visit 1 (day 1) to visit 2 (day 8)
Collection of adverse events (AEs) during the period of use of HMG, PHN, PHR, TUR products in an electronic daily recording book
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Chu Clermont Ferrand | Clermont-Ferrand | France | Recruiting |
More University Hospital, Clermont-Ferrand trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07569939 on ClinicalTrials.gov ↗ ← All trials in France